| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 22.682 | 140.173 | 184.750 | 395.102 |
| Total Income - EUR | - | - | - | - | - | - | 22.682 | 140.174 | 184.751 | 395.104 |
| Total Expenses - EUR | - | - | - | - | - | - | 47.644 | 197.684 | 195.817 | 389.016 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -24.961 | -57.510 | -11.066 | 6.088 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -25.189 | -58.913 | -12.975 | 4.941 |
| Employees | - | - | - | - | - | - | 5 | 3 | 3 | 4 |
Check the financial reports for the company - Farmaciile Exmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 55.059 | 66.276 | 63.731 | 63.162 |
| Current Assets | - | - | - | - | - | - | 135.646 | 150.513 | 158.331 | 162.813 |
| Inventories | - | - | - | - | - | - | 100.784 | 85.881 | 87.735 | 84.423 |
| Receivables | - | - | - | - | - | - | 32.182 | 62.832 | 65.036 | 73.929 |
| Cash | - | - | - | - | - | - | 2.680 | 1.800 | 5.560 | 4.460 |
| Shareholders Funds | - | - | - | - | - | - | -25.148 | -84.140 | -96.859 | -91.377 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 215.975 | 301.004 | 318.991 | 317.456 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmaciile Exmed S.r.l.